Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

CF AMR Syndicate Announces First Awardees of £3m Collaborative Drug Discovery Programme

The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.

The £3 million programme, funded by LifeArc, will support six early-stage novel antimicrobial projects over two years to accelerate new treatments for lung infections in people with CF.

Commercialisation Manager

About the role

The role of the Commercialisation Manager is to support the Head of BDI in delivering Knowledge Exchange, Commercialisation, and Impact Strategies.

The main purpose of the job will be to drive commercialisation of our research, grow the entrepreneurial culture, and help the institute to secure new income.

The key aspects of the role fall into the following areas:

Seamless Protein–Ligand Docking Workflows for Computational and Medicinal Chemists

Cambridge, UK – September 20th 2024 - The Cambridge Crystallographic Data Centre (CCDC) is pleased to announce the integration of our industry-validated Genetic Optimization for Ligand Docking (GOLD) software with Cadence Molecular Sciences (OpenEye)’s Orion platform. This collaboration provides computational and medicinal chemists with a powerful new toolset to streamline and enhance their protein–ligand docking workflows on Cadence Molecular Sciences cloud-native Orion platform, a crucial step in pharmaceutical development. 

Be part of the next Discovery Spark cohort – Applications closing soon!

Discovery Spark is a transformative innovation growth programme for early-stage companies, packed with invaluable resources and support. Across a number of in-person sessions led by seasoned professionals and industry leaders, participants will gain the essential skills needed to lay robust foundations in their business and prepare for investment. Discovery Spark is aimed at businesses across a diverse range of sectors including biotech, medtech, diagnostics and advanced therapies and those who have raised up to £1 million in equity.

CDD European Life Science Community Meeting

Collaborative Drug Discovery Community Meeting brings the European technology and scientific communities together. This year is special as we are celebrating CDD's 20 years of excellence.

We invite you to join us to learn about the latest life science industry trends, discuss research data strategies on best practices with peers, explore CDD Vault, get personalized training, listen to engaging keynotes, and network with industry experts. 

The distinguished line-up of speakers include:

PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes

  • Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform
  • Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Management

NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman

  • Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind
  • Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of the technology platform
  • Novel “nanosyringe” platform can deliver complex biologic payloads selectively and intracellularly, unlocking the interior of the cell for new intervention possibilities in unmet medical needs
Subscribe to